---
figid: PMC3874419__nihms488113f4
figtitle: Cross-talk of EGFR/HER2 signaling with other pathways
organisms:
- Homo sapiens
- Mus musculus
- clinical samples
pmcid: PMC3874419
filename: nihms488113f4.jpg
figlink: /pmc/articles/PMC3874419/figure/F4/
number: F4
caption: Cross-talk of EGFR/HER2 signaling with other pathways. Wnt/β-catenin, Notch
  and TNFα/IKK/NF-κB signaling pathway can cross-talk with the EGFR/HER2 pathway at
  various points and affect the sensitivity to EGFR/HER2 inhibitors. Notch target
  gene HES1 encodes a transcription repressor that can inhibit the expression of DUSP1
  and PTEN, which are negative regulators for ERK and AKT, respectively. IKK activated
  by TNFα has several common targets with ERK and AKT, including FOXO3, TSC complex.
  In the Wnt/β-catenin pathway, GSK3β, a negative regulator of this pathway, is phosphorylated
  and inactivated by AKT and ERK. GSK3β can phosphorylate and induce β-TrCP-mediated
  degradation of RAS.
papertitle: Signaling cross-talk in the resistance to HER family receptor targeted
  therapy.
reftext: H. Yamaguchi, et al. Oncogene. ;33(9):1073-1081.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9534022
figid_alias: PMC3874419__F4
figtype: Figure
organisms_ner:
- Mus musculus
- Homo sapiens
redirect_from: /figures/PMC3874419__F4
ndex: 0b4bac2a-deef-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3874419__nihms488113f4.html
  '@type': Dataset
  description: Cross-talk of EGFR/HER2 signaling with other pathways. Wnt/β-catenin,
    Notch and TNFα/IKK/NF-κB signaling pathway can cross-talk with the EGFR/HER2 pathway
    at various points and affect the sensitivity to EGFR/HER2 inhibitors. Notch target
    gene HES1 encodes a transcription repressor that can inhibit the expression of
    DUSP1 and PTEN, which are negative regulators for ERK and AKT, respectively. IKK
    activated by TNFα has several common targets with ERK and AKT, including FOXO3,
    TSC complex. In the Wnt/β-catenin pathway, GSK3β, a negative regulator of this
    pathway, is phosphorylated and inactivated by AKT and ERK. GSK3β can phosphorylate
    and induce β-TrCP-mediated degradation of RAS.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Egfr
  - Tnfrsf1a
  - Pik3r1
  - Pten
  - Gsk3b
  - ras
  - Hras
  - Kras
  - Rem1
  - Akt1
  - Hes1
  - Hesx1
  - Dusp1
  - Mdk
  - Nfkb1
  - Ctnnb1
  - Ephb2
  - Mapk1
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - EGFR
  - NOTCH1
  - NOTCH2
  - NOTCH3
  - NOTCH4
  - TNFRSF1A
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - PTEN
  - GSK3B
  - KRAS
  - HRAS
  - NRAS
  - AKT1
  - AKT2
  - AKT3
  - HES1
  - GATD3
  - DUSP1
  - DUSP12
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - NFKB1
  - CTNNB1
  - EPHB2
  - MAPK1
  - MAPK3
  - Cancer
  - Lung cancer
---
